| P50 | author | Karen Sliwa | Q28484205 |
| | Neil H. Davies | Q55126850 |
| | Friedrich Thienemann | Q55523569 |
| | Ghazwan Butrous | Q73568795 |
| P2093 | author name string | Gerald Maarman | |
| | Sandrine Lecour | |
| | Dee Blackhurst | |
| | Lori Blauwet | |
| P2860 | cites work | Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension | Q21284417 |
| | A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet? | Q27026643 |
| | Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells | Q28374556 |
| | Dose translation from animal to human studies revisited | Q29618049 |
| | Updated clinical classification of pulmonary hypertension. | Q30378433 |
| | Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension | Q33712644 |
| | Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective | Q34118964 |
| | Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection | Q34166155 |
| | Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension | Q34275313 |
| | Mechanisms of right heart failure-A work in progress and a plea for failure prevention | Q34343977 |
| | Oxidative stress in patients with COPD and pulmonary hypertension. | Q34658845 |
| | Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In | Q34999923 |
| | Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension. | Q35289907 |
| | Regulation of antioxidant enzymes: a significant role for melatonin | Q35607606 |
| | Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial | Q36372805 |
| | Microtubule proliferation in right ventricular myocytes of rats with monocrotaline-induced pulmonary hypertension | Q36708371 |
| | Reactive oxygen species and antioxidants in pulmonary hypertension | Q36747034 |
| | The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension | Q37407624 |
| | Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin | Q37786174 |
| | Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart. | Q37801163 |
| | Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective | Q37846912 |
| | The monocrotaline model of pulmonary hypertension in perspective | Q37941438 |
| | Emergence of naturally occurring melatonin isomers and their proposed nomenclature | Q37983883 |
| | Right ventricular adaptation and maladaptation in chronic pulmonary arterial hypertension | Q38006785 |
| | WHO Group 1 pulmonary arterial hypertension: current and investigative therapies | Q38046294 |
| | Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. | Q38172724 |
| | Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era. | Q38199493 |
| | A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. | Q38250438 |
| | Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. | Q40536989 |
| | Contribution of oxidative stress to pulmonary arterial hypertension | Q41137411 |
| | Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure | Q43198442 |
| | Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart. | Q43280246 |
| | Melatonin protects against cardiac toxicity of doxorubicin in rat. | Q43795911 |
| | Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection | Q44022447 |
| | Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations | Q44208373 |
| | Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension | Q44473667 |
| | Oxidative stress in severe pulmonary hypertension | Q44710488 |
| | Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats | Q44963004 |
| | Serial noninvasive assessment of apoptosis during right ventricular disease progression in rats. | Q45925589 |
| | Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. | Q45956944 |
| | Antifibrotic effect of melatonin--perspective protection in hypertensive heart disease | Q46399506 |
| | Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells | Q46435567 |
| | Ceramide-induced preconditioning involves reactive oxygen species | Q46722860 |
| | Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction | Q46869642 |
| | Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. | Q48385253 |
| | Concomitant consumption of red wine and polyunsaturated fatty acids in edible oil does not influence the peroxidation status of chylomicron lipids despite increasing plasma catechin concentration. | Q50713831 |
| | Electrophysiologic Remodeling of the Left Ventricle in Pressure Overload-Induced Right Ventricular Failure | Q54952170 |
| | Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. | Q55042633 |
| | Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat | Q57298870 |
| | Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep | Q57817366 |
| | Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure | Q57825824 |
| | Pulmonary Arterial Hypertension | Q58485998 |
| | Melatonin Reduces Night Blood Pressure in Patients with Nocturnal Hypertension | Q58855300 |
| P433 | issue | 3 | |
| P304 | page(s) | 343-353 | |
| P577 | publication date | 2015-07-22 | |
| P1433 | published in | Journal of Pineal Research | Q15056565 |
| P1476 | title | Melatonin as a preventive and curative therapy against pulmonary hypertension | |
| P478 | volume | 59 | |